US firms K&L Gates, Covington & Burling and Orrick, Herrington & Sutcliffe are the latest to take on partners from the beleaguered European practice of King & Wood Mallesons (KWM).
Herbert Smith Freehills (HSF) and Latham & Watkins won lead roles on Baxter International’s acquisition of Claris Injectables for $625m, in a bid by Baxter to expand its portfolio of essential generic injectable medicines. HSF represented Claris, while Latham acted for Baxter.
DLA Piper and Greenberg Traurig are the latest to benefit from a swathe of exits at King & Wood Mallesons (KWM) European arm.
King & Wood Mallesons has incorporated a new limited liability partnership on Companies House called ‘KWM Deutschland’.
Latham & Watkins announced today (13 December) that it has hired Herbert Smith Freehills’s (HSF) global energy co-head John Balsdon, who will join its finance team in the City.
Partners at King & Wood Mallesons (KWM) have been told at a partnership meeting today (9 December) of a shortlist of potential suitors as the European partnership enters deeper discussions for a rescue deal.
Advisory roles in Sumitomo Corporation’s €751m takeover of Irish banana firm Fyffes have been split between a raft of US and Irish firms including Morgan, Lewis & Bockius, Skadden, Arps, Slate, Meagher & Flom, A&L Goodbody and Arthur Cox.
Revenue at the London and Paris outposts of US firm King & Spalding surged 11% in 2015 to £41.9m as the firm continues expanding, but profit dropped by 10%.
Barclays has moved to take extra security over King & Wood Mallesons‘ assets with a second debenture, Companies House records show.
Legacy SJ Berwin on the brink as global managing partner stands down Persistent troubles at King & Wood Mallesons’ (KWM) beleaguered European arm came to a head in November as the partnership, which is carrying more than £30m in debt, failed to get a deal over the line to recapitalise its business. As Legal Business …
